The Prosecutor General’s Office announced on Tuesday that the DNA tests confirmed that Dan Condrea was the driver killed in the car crash that occurred in Corbeanca on May 22, prosecutors pointing out that the car owned by him had been seen going back and forth 13 times on a stretch of road that evening.
“The blood and tissue samples found on the car during the investigations carried out at the scene show a genetic profile identical to the biological samples taken from the dead body. The genetic profile belongs to a man who is the biological father of minor C.D., with a paternity index of 5,580,000,” the High Court Prosecutor General’s Office states in a press release.
Prosecutors point out that “a CCTV camera located in Buftea recorded the auto vehicle involved in the aforementioned car crash being driven from Buftea to Corbeanca and back, the car appearing in the footage for a total of 13 times, from 5.31 p.m. to 6.38 p.m., being last seen going from Buftea to Corbeanca.”
The computer forensics investigations are ongoing, several examinations set to be carried out into the way the car crash took place.
On a different plane, the Prosecutor General’s Office is investigating offences related to the marketing of Hexi Pharma products that turned out not to be in conformity with standards, the offences probed being fraud and thwarting the combating of diseases. At this moment, prosecutors are not probing the way public hospitals awarded contracts to Hexi Pharma, the verification of the public procurements being handled by the Premier’s Audit Body, judicial sources explained.
On May 17, several samples from biocide products made by Hexi Pharma and used in hospitals where tests showed they were not in conformity with standards were taken to the Cantacuzino Institute. The Institute will complete its own tests within 30 days’ time, the prosecutors’ expenditures on the tests carried out in this case being estimated at EUR 7-8,000 so far, the aforementioned sources claim.
In the legal case concerning the thwarting of combating diseases, Hexi Pharma General Manager Flori Dinu has been placed under house arrest, being charged with 99 counts of fraud (continued offence), 29 counts of fraud and improper involvement in thwarting the combating of diseases. Judicial sources have pointed out that the woman made statements in court when the prosecutors’ request to have her placed under pre-trial arrest was analysed.
Likewise, Mihai Leva, Head of Production at Hexi Pharma, is being criminally probed for being an accessory to improper involvement in the thwarting of combating diseases (continued offence). He is being investigated while remanded under conditional bail.